Evidence map›Paper›PMID 35317091›Full record

ArticleJournal of medical cases2022

Toxic Epidermal Necrolysis-Like Lupus Erythematous Presentation Following SARS-CoV-2 Infection.

Ana Luisa Nunes, Leonor Simoes, Carolina Figueiredo, Ruben Carvalho, Jandira Lima, Rui M Santos

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Luisa NunesInternal Medicine Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Leonor SimoesIntensive Medicine Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Carolina FigueiredoDermatology Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Ruben CarvalhoInfectious Diseases Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Jandira LimaInternal Medicine Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Rui M SantosInternal Medicine Department, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra 3004-561, Portugal.
Hospitais da Universidade de Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organs. Infectious agents have been implicated in the pathogenesis of SLE. The emergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a pro-inflammatory cytokine storm and has been linked to autoimmune phenomena, which can lead to the onset of autoimmune diseases. We report the case of a 70-year-old patient who developed a toxic epidermal necrolysis (TEN)-like subacute cutaneous lupus (SCL) as a severe presentation of SLE, 1 month after SARS-CoV-2 infection. After excluding other causes of SLE, treatment was initiated with a successful outcome.

Indexed as

COVID-19SARS-CoV-2Subacute cutaneous lupusSystemic lupus erythematousToxic epidermal necrolysis

Identifiers

PMID35317091
PMCPMC8913004
OpenAlexW4213040779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.